Novo investors call for dealmaking and new drugs
Investors urge the Ozempic maker to diversify its portfolio as it prepares to face shareholders on Monday.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Novo
- Ozempic